MarketingRx roundup: Genentech doubles down on anti-racism; Eli Lilly rolls first social video on $35 or less insulin
Genentech is amplifying its commitment — and increasing its pledges — to counter systemic racism in healthcare and education. The Roche company and its Genentech Foundation recently committed $17 million to 31 grantees, a 40% increase over its last round of $12 million in funding pledges in 2022.
It’s also prioritized diverse and representative teams, with 94% of the grantee groups led or co-led by people of color. That’s up from 70% last year.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters
